RecruitingNot ApplicableNCT04993131

Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma

Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma: a Prospective Exploratory Trial


Sponsor

Oslo University Hospital

Enrollment

15 participants

Start Date

Sep 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The study will investigate whether liver transplantation provides increased survival, low side effects and good quality of life in patients with bile duct cancer where the tumor cannot be removed by normal surgery. Analyzes of blood and tissue samples from the tumor will be investigated to see if the analyzes can indicate who may have recurrence of the disease after liver transplantation. Furthermore, the effect of chemotherapy on normal liver and tumor tissues in the liver that are removed during transplantation will be investigated.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether liver transplantation can be a viable treatment for patients with a rare bile duct cancer called perihilar cholangiocarcinoma that cannot be surgically removed. To qualify, patients must first show their cancer is stable or responding to chemotherapy. **You may be eligible if...** - You are 18 or older with a suspected bile duct cancer (perihilar cholangiocarcinoma) that cannot be surgically removed due to its location or underlying liver problems - There is no sign of cancer spread outside the liver on imaging - You have been on chemotherapy for at least 6 months with at least 10% tumor shrinkage - It has been at least 10–12 months since diagnosis - You are in good overall health (ECOG 0–1) with adequate blood tests - You have been accepted as a transplant candidate **You may NOT be eligible if...** - Your tumor involves major blood vessels (main portal vein, vena cava, celiac artery) - You have lost more than 15% of your body weight in 6 months - Your BMI is above 30 - You have another active cancer (unless treated and cured more than 5 years ago) - You have HIV, a prior organ transplant, or substance abuse issues - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELiver transplant

Liver transplant.


Locations(1)

Oslo university hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04993131


Related Trials